These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 19438508)

  • 1. IGF-1 derived small neuropeptides and analogues: a novel strategy for the development of pharmaceuticals for neurological conditions.
    Guan J; Gluckman PD
    Br J Pharmacol; 2009 Jul; 157(6):881-91. PubMed ID: 19438508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor -1 (IGF-1) derived neuropeptides, a novel strategy for the development of pharmaceuticals for managing ischemic brain injury.
    Guan J
    CNS Neurosci Ther; 2011 Aug; 17(4):250-5. PubMed ID: 20236140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor-1 and its derivatives: potential pharmaceutical application for ischemic brain injury.
    Guan J
    Recent Pat CNS Drug Discov; 2008 Jun; 3(2):112-27. PubMed ID: 18537771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor-1 and its derivatives: potential pharmaceutical application for treating neurological conditions.
    Guan J; Mathai S; Liang HP; Gunn AJ
    Recent Pat CNS Drug Discov; 2013 Aug; 8(2):142-60. PubMed ID: 23597305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role for IGF-1-derived small neuropeptides as a therapeutic target for neurological disorders.
    Guan J; Harris P; Brimble M; Lei Y; Lu J; Yang Y; Gunn AJ
    Expert Opin Ther Targets; 2015 Jun; 19(6):785-93. PubMed ID: 25652713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective effects of the N-terminal tripeptide of insulin-like growth factor-1, glycine-proline-glutamate (GPE) following intravenous infusion in hypoxic-ischemic adult rats.
    Guan J; Thomas GB; Lin H; Mathai S; Bachelor DC; George S; Gluckman PD
    Neuropharmacology; 2004 Nov; 47(6):892-903. PubMed ID: 15527823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral administration of a novel diketopiperazine, NNZ 2591, prevents brain injury and improves somatosensory-motor function following hypoxia-ischemia in adult rats.
    Guan J; Mathai S; Harris P; Wen JY; Zhang R; Brimble M; Gluckman P
    Neuropharmacology; 2007 Nov; 53(6):749-62. PubMed ID: 17904590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GPE and GPE analogues as promising neuroprotective agents.
    Cacciatore I; Cornacchia C; Baldassarre L; Fornasari E; Mollica A; Stefanucci A; Pinnen F
    Mini Rev Med Chem; 2012 Jan; 12(1):13-23. PubMed ID: 22070686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of intracerebroventricular application of insulin-like growth factor 1 and its N-terminal tripeptide on cerebral recovery following cardiac arrest in rats.
    Knapp J; Teschendorf P; Vogel P; Bruckner T; Böttiger BW; Popp E
    Resuscitation; 2013 May; 84(5):684-9. PubMed ID: 23103885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NNZ-2566, a glypromate analog, improves functional recovery and attenuates apoptosis and inflammation in a rat model of penetrating ballistic-type brain injury.
    Lu XC; Chen RW; Yao C; Wei H; Yang X; Liao Z; Dave JR; Tortella FC
    J Neurotrauma; 2009 Jan; 26(1):141-54. PubMed ID: 19119917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining insulin-like growth factor derivatives plus caffeinol produces robust neuroprotection after stroke in rats.
    Zhao X; Liu SJ; Zhang J; Strong R; Aronowski J; Grotta JC
    Stroke; 2005 Jan; 36(1):129-34. PubMed ID: 15569874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-terminal tripeptide of IGF-1 improves functional deficits after 6-OHDA lesion in rats.
    Krishnamurthi R; Stott S; Maingay M; Faull RL; McCarthy D; Gluckman P; Guan J
    Neuroreport; 2004 Jul; 15(10):1601-4. PubMed ID: 15232291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective effects of the N-terminal tripeptide of IGF-1, glycine-proline-glutamate, in the immature rat brain after hypoxic-ischemic injury.
    Sizonenko SV; Sirimanne ES; Williams CE; Gluckman PD
    Brain Res; 2001 Dec; 922(1):42-50. PubMed ID: 11730700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanism underlying the cerebral effect of Gly-Pro-Glu tripeptide bound to L-dopa in a Parkinson's animal model.
    Minelli A; Conte C; Cacciatore I; Cornacchia C; Pinnen F
    Amino Acids; 2012 Sep; 43(3):1359-67. PubMed ID: 22218995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed peripheral administration of a GPE analogue induces astrogliosis and angiogenesis and reduces inflammation and brain injury following hypoxia-ischemia in the neonatal rat.
    Svedin P; Guan J; Mathai S; Zhang R; Wang X; Gustavsson M; Hagberg H; Mallard C
    Dev Neurosci; 2007; 29(4-5):393-402. PubMed ID: 17762207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment in animal models.
    Guan J; Bennet L; Gluckman PD; Gunn AJ
    Endocr Dev; 2005; 9():31-43. PubMed ID: 15879686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed peripheral administration of the N-terminal tripeptide of IGF-1 (GPE) reduces brain damage following microsphere induced embolic damage in young adult and aged rats.
    Shapira S; Mathai S; Zhang R; Guan J
    Neurosci Lett; 2009 Apr; 454(1):53-7. PubMed ID: 19429053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement in inflammation is associated with the protective effect of Gly-Pro-Glu and cycloprolylglycine against Aβ-induced depletion of the hippocampal somatostatinergic system.
    Aguado-Llera D; Canelles S; Fernández-Mendívil C; Frago LM; Argente J; Arilla-Ferreiro E; López MG; Barrios V
    Neuropharmacology; 2019 Jun; 151():112-126. PubMed ID: 30981749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central penetration and stability of N-terminal tripeptide of insulin-like growth factor-I, glycine-proline-glutamate in adult rat.
    Baker AM; Batchelor DC; Thomas GB; Wen JY; Rafiee M; Lin H; Guan J
    Neuropeptides; 2005 Apr; 39(2):81-7. PubMed ID: 15752541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NNZ-2566: a Gly-Pro-Glu analogue with neuroprotective efficacy in a rat model of acute focal stroke.
    Bickerdike MJ; Thomas GB; Batchelor DC; Sirimanne ES; Leong W; Lin H; Sieg F; Wen J; Brimble MA; Harris PW; Gluckman PD
    J Neurol Sci; 2009 Mar; 278(1-2):85-90. PubMed ID: 19157421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.